The Changing Landscape of Nontuberculous Mycobacterial Lung Disease (NTM-LD):A 3D View of Pathogenesis, Diagnosis, and Management
Tuesday, May 21, 2019
6:30PM – 7:00PM: Registration and Dinner
7:00PM – 9:00PM: Symposium
Hyatt Regency Dallas
300 Reunion Boulevard
Dallas, TX 75207
Meeting room: Landmark Ballroom C, 1st Floor
– iPads provided to enhance learning experience
– Create your own personalized poster
– Intimate, case-based learning environment
– 3D Glasses provided to all attendees
Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor of Medicine National Jewish Health
Kevin Winthrop, MD, MPH
Professor, Public Health, Infectious Disease & Ophthalmology
Oregon Health & Science University
After completing the CME activity, learners should be better able to:
- Review the microbiology, pathogenesis and environmental aspects of NTM.
- Describe how to personalize treatment goals for patients with NTM-LD based on health status, comorbidities and patient preferences.
- Assess strategies for preventing drug-related adverse events in treatment of patients with NTM-LD.
- Evaluate clinical data on the efficacies of established & emerging therapies for patients with NTM-LD.
This activity is intended to meet the educational needs of infectious disease specialists, pulmonologists, internal medicine specialists, nurses, pharmacists, and other professionals involved in the care of patients with NTM-LD.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at firstname.lastname@example.org
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at email@example.com.
Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.